Carcinoma in situ of lung (disorder)
CONCORDE: A Platform study of DNA damage response inhibitors in combination with conventional radiotherapy in non small cell lung cancer
Year Started: 2021
Archival tumour biopsies, Circulating Free DNA (cfDNA), Peripheral Blood Mononuclear Cell (PBMC), Toxicity Biomarkers
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
-
No restrictions
Associated Data Type |
Procurement Timeframe |
There is no associated data for this collection. |
Undifferentiated
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
|
RT |
Paraffin |
Not applicable |
11 - 25% |
Undifferentiated
Adult (> 40 years)
101 - 500 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Whole blood |
|
-60°C to -85°C |
|
Not applicable |
0 - 10% |
Undifferentiated
Adult (> 40 years)
101 - 500 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Whole blood |
|
-60°C to -85°C |
|
Not applicable |
0 - 10% |
Undifferentiated
Adult (> 40 years)
101 - 500 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Whole blood |
|
-60°C to -85°C |
|
Not applicable |
0 - 10% |